Dopamine and schizophrenia. A reappraisal in the light of clinical studies with clozapine.
D000284:Administration, Oral; D000328:Adult; D001921:Brain / Q000378:metabolism*; D010054:Brief Psychiatric Rating Scale; D002908:Chronic Disease; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D003984:Dibenzazepines; D011954:Receptors, Dopamine; D003024:Clozapine; D004298:Dopamine